-
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) shares
jumped 40.5 percent to $13.19 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients
with disease progression on or after PD-1 therapies.
-
Cemtrex Inc (NASDAQ: CETX) shares climbed 36.5
percent to $4.30 after the company disclosed that it has received over $21 million in new orders in April.
-
Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB)
shares surged 19.7 percent to $69.45 as the company reported upbeat results for its first quarter. Bank of America upgraded Red
Robin from Neutral to Buy.
-
China Commercial Credit Inc (NASDAQ: CCCR) shares
climbed 17.5 percent to $2.35.
-
Omeros Corporation (NASDAQ: OMER) shares rose
14.6 percent to $17.13 as the company reported the completion of IgA nephropathy cohort in OMS721 Phase 2 clinical trial.
-
Pyxis Tankers Inc (NASDAQ: PXS) gained 14.4
percent to $1.59. Pyxis Tankers is scheduled to release unaudited results for the three months ended March 31, 2017 on May 18,
2017.
-
Helios and Matheson Analytics Inc (NASDAQ: HMNY)
shares surged 14 percent to $2.54.
-
Coherus Biosciences Inc (NASDAQ: CHRS) shares
rose 8 percent to $23.80. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
-
Qiwi PLC (NASDAQ: QIWI) gained 7.7 percent to
$21.40 after reporting strong quarterly results.
-
Jack in the Box Inc. (NASDAQ: JACK) shares gained
7.3 percent to $109.29 after the company posted better-than-expected earnings for its second quarter. The company also
disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
-
xG Technology Inc (NASDAQ: XGTI) shares climbed 7
percent to $2.16.
-
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) gained 6.4 percent to $2.08. Cantor Fitzgerald upgraded BioDelivery
Sciences from Neutral to Overweight.
-
Citi Trends, Inc. (NASDAQ: CTRN) climbed 3.2
percent to $18.44 as the company posted in-line quarterly earnings and raised its quarterly dividend to $0.08 per share.
-
Target Corporation (NYSE: TGT) shares rose 3 percent
to $56.12 after the company reported stronger-than-expected results for its first quarter.
-
Colgate-Palmolive Company (NYSE: CL) shares rose 3
percent to $73.71 after the NY Post reported that the company might be up for sale for $100 per share.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.